216 related articles for article (PubMed ID: 25143462)
1. Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine.
Gonen A; Hansen LF; Turner WW; Montano EN; Que X; Rafia A; Chou MY; Wiesner P; Tsiantoulas D; Corr M; VanNieuwenhze MS; Tsimikas S; Binder CJ; Witztum JL; Hartvigsen K
J Lipid Res; 2014 Oct; 55(10):2137-55. PubMed ID: 25143462
[TBL] [Abstract][Full Text] [Related]
2. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.
Binder CJ; Hartvigsen K; Chang MK; Miller M; Broide D; Palinski W; Curtiss LK; Corr M; Witztum JL
J Clin Invest; 2004 Aug; 114(3):427-37. PubMed ID: 15286809
[TBL] [Abstract][Full Text] [Related]
3. Human monoclonal Fab and human plasma antibodies to carbamyl-epitopes cross-react with malondialdehyde-adducts.
Kummu O; Turunen SP; Prus P; Lehtimäki J; Veneskoski M; Wang C; Hörkkö S
Immunology; 2014 Mar; 141(3):416-30. PubMed ID: 24168430
[TBL] [Abstract][Full Text] [Related]
4. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.
Freigang S; Hörkkö S; Miller E; Witztum JL; Palinski W
Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1972-82. PubMed ID: 9848892
[TBL] [Abstract][Full Text] [Related]
5. Immunization with gingipain A hemagglutinin domain of Porphyromonas gingivalis induces IgM antibodies binding to malondialdehyde-acetaldehyde modified low-density lipoprotein.
Kyrklund M; Kummu O; Kankaanpää J; Akhi R; Nissinen A; Turunen SP; Pussinen P; Wang C; Hörkkö S
PLoS One; 2018; 13(1):e0191216. PubMed ID: 29329335
[TBL] [Abstract][Full Text] [Related]
6. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.
Turunen SP; Kummu O; Wang C; Harila K; Mattila R; Sahlman M; Pussinen PJ; Hörkkö S
Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521
[TBL] [Abstract][Full Text] [Related]
7. Specific recognition of malondialdehyde and malondialdehyde acetaldehyde adducts on oxidized LDL and apoptotic cells by complement anaphylatoxin C3a.
Veneskoski M; Turunen SP; Kummu O; Nissinen A; Rannikko S; Levonen AL; Hörkkö S
Free Radic Biol Med; 2011 Aug; 51(4):834-43. PubMed ID: 21683785
[TBL] [Abstract][Full Text] [Related]
8. Malondialdehyde-Acetaldehyde Modified (MAA) Proteins Differentially Effect the Inflammatory Response in Macrophage, Endothelial Cells and Animal Models of Cardiovascular Disease.
Duryee MJ; Clemens DL; Opperman PJ; Thiele GM; Duryee LM; Garvin RP; Anderson DR
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884754
[TBL] [Abstract][Full Text] [Related]
9. B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.
Rosenfeld SM; Perry HM; Gonen A; Prohaska TA; Srikakulapu P; Grewal S; Das D; McSkimming C; Taylor AM; Tsimikas S; Bender TP; Witztum JL; McNamara CA
Circ Res; 2015 Jul; 117(3):e28-39. PubMed ID: 26082558
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice.
Sun J; Hartvigsen K; Chou MY; Zhang Y; Sukhova GK; Zhang J; Lopez-Ilasaca M; Diehl CJ; Yakov N; Harats D; George J; Witztum JL; Libby P; Ploegh H; Shi GP
Circulation; 2010 Aug; 122(8):808-20. PubMed ID: 20697023
[TBL] [Abstract][Full Text] [Related]
11. Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis.
Duryee MJ; Klassen LW; Schaffert CS; Tuma DJ; Hunter CD; Garvin RP; Anderson DR; Thiele GM
Free Radic Biol Med; 2010 Nov; 49(10):1480-6. PubMed ID: 20696236
[TBL] [Abstract][Full Text] [Related]
12. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.
Klingenberg R; Lebens M; Hermansson A; Fredrikson GN; Strodthoff D; Rudling M; Ketelhuth DF; Gerdes N; Holmgren J; Nilsson J; Hansson GK
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):946-52. PubMed ID: 20167655
[TBL] [Abstract][Full Text] [Related]
13. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis.
Zhou X; Caligiuri G; Hamsten A; Lefvert AK; Hansson GK
Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):108-14. PubMed ID: 11145941
[TBL] [Abstract][Full Text] [Related]
14. SYK regulates macrophage MHC-II expression via activation of autophagy in response to oxidized LDL.
Choi SH; Gonen A; Diehl CJ; Kim J; Almazan F; Witztum JL; Miller YI
Autophagy; 2015; 11(5):785-95. PubMed ID: 25946330
[TBL] [Abstract][Full Text] [Related]
15. T cell proliferative responses to malondialdehyde-acetaldehyde haptenated protein are scavenger receptor mediated.
Willis MS; Thiele GM; Tuma DJ; Klassen LW
Int Immunopharmacol; 2003 Oct; 3(10-11):1381-99. PubMed ID: 12946435
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells pulsed with malondialdehyde modified low density lipoprotein aggravate atherosclerosis in Apoe(-/-) mice.
Hjerpe C; Johansson D; Hermansson A; Hansson GK; Zhou X
Atherosclerosis; 2010 Apr; 209(2):436-41. PubMed ID: 19897195
[TBL] [Abstract][Full Text] [Related]
17. Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis.
Dunér P; To F; Beckmann K; Björkbacka H; Fredrikson GN; Nilsson J; Bengtsson E
Cardiovasc Res; 2011 Aug; 91(3):528-36. PubMed ID: 21493703
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis.
Schiopu A; Bengtsson J; Söderberg I; Janciauskiene S; Lindgren S; Ares MP; Shah PK; Carlsson R; Nilsson J; Fredrikson GN
Circulation; 2004 Oct; 110(14):2047-52. PubMed ID: 15451805
[TBL] [Abstract][Full Text] [Related]
19. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis.
George J; Afek A; Gilburd B; Levkovitz H; Shaish A; Goldberg I; Kopolovic Y; Wick G; Shoenfeld Y; Harats D
Atherosclerosis; 1998 May; 138(1):147-52. PubMed ID: 9678780
[TBL] [Abstract][Full Text] [Related]
20. Assays for acetaldehyde-derived adducts in blood proteins based on antibodies against acetaldehyde/lipoprotein condensates.
Latvala J; Melkko J; Parkkila S; Järvi K; Makkonen K; Niemelä O
Alcohol Clin Exp Res; 2001 Nov; 25(11):1648-53. PubMed ID: 11707639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
